Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

antarelix

Known as: D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-, teverelix acetate, teverelix 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
GPR147 and its endogenous ligands, RFRPs, are emerging as important actors in hypothalamic‐pituitary axis control. The role of… Expand
2004
2004
Rats were rendered tolerant to the motor-impairing effects of ethanol by daily oral administration. Subsequently, ethanol was… Expand
  • figure 1
  • figure 2
  • figure 3
2004
2004
The aim of this study was to determine, for goats, the effects of daily doses of GnRH antagonist on ovarian endocrine and… Expand
2003
2003
Teverelix microspheres were produced by coacervation using a new type of poly(ester-carbonates) made of block copolymers of poly… Expand
2003
2003
The GnRH antagonist antarelix (Teverelix) was administered to mares (0.01 mg/kg, i.v., twice a day) during the periovulatory… Expand
Highly Cited
2002
Highly Cited
2002
Preovulatory GnRH secretion in ewes, measured in portal blood and cerebrospinal fluid, starts at the time of the LH surge… Expand
2000
2000
Teverelix is a novel synthetic peptidic luteinizing hormone‐releasing hormone (LHRH) antagonist. 
1993
1993
A novel water soluble LHRH antagonist (EP 24332-Antarelix) is described. Its activity in vitro and in vivo in several animal… Expand
1987
1987
N-(Trifluoroacetyl)-l-prolyl- (N-TFA-l-prolyl-) d- and l-amphetamine diastereoisomers were separated by high-performance liquid… Expand
1986
1986
We studied the effects of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on gastric secretion and various acute and chronic… Expand